Research

Cannabis Science and Technology is proud to announce a partnership with the American Chemical Society’s (ACS) Cannabis Chemistry Subdivision (CANN) that will kick-off with the “Spring 2020 CANN Virtual Symposium” on May 6–7.

A report on the top authors, most prevalent terms, and emerging trends in peer-reviewed cannabis science articles.

Dmitry Kurouski discusses the groundbreaking work his team is conducting using a handheld Raman spectrometer to identify cannabis and hemp plants.

A large data set from Washington (140,000 flower samples) is scrutinized here for evidence of consistently propagated strains with higher than a 2-to-1 ratio.

Our first market profile of 2020 reviews the cannabis laboratory testing market in the U.S. and Canada.

Part I of this article series focuses on the physiology of heavy metal transport and translocation into and within plant tissues.

Dr. Sue Sisley has been pioneering research in the U.S. cannabis industry and fighting for quality cannabis samples to conduct her clinical trials. We recently spoke to her about the challenges she’s faced, what’s ahead for her future research, and more.

Dr. Sue Sisley has been pioneering research in the U.S. cannabis industry and fighting for quality cannabis samples to conduct her clinical trials. We recently spoke to her about the challenges she’s faced, what’s ahead for her future research, and more.

A review of a study on vapes found four major factors related to the production of vape cartridges that warrant additional attention: cutting agents, temperature, flavoring, and hardware and heavy metals.

Currently in the cannabis industry, the standards and benchmarks for drug delivery, analytics and testing, consumer reporting, and packaging are basic in nature with substantial room for more sophistication and technology. Here’s how it can be improved.

Giuseppe Cannazza discusses the discovery of two new cannabinoids: ∆9-tetrahydrocannabiphorol (THCP) and cannabidiphorol (CBDP).

Commentary on how medicinal cannabis can evolve in a similar manner as the pharmaceutical industry did.

A long history of cannabis discoveries and research has put Israel at the forefront of medical cannabis developments, worldwide collaborations, and investor activity.

A long history of cannabis discoveries and research has put Israel at the forefront of medical cannabis developments, worldwide collaborations, and investor activity.

A review of the literature to examine the analgesic properties of cannabis.

A review of the literature to examine the analgesic properties of cannabis.

The National Center for Complementary and Integrative Health (NCCIH), part of the NIH, announced funding for nine new research awards totaling $3 million to study the potential pain-relieving properties of cannabinoids and terpenes in cannabis.

Lake Superior State University (LSSU) announced a strategic partnership with Agilent Technologies to facilitate education and research in cannabis chemistry and analysis through the LSSU Cannabis Center of Excellence (CoE).

This review introduces a quantitative polymerase chain reaction (qPCR) assay and compares its performance to culture-based methods.

This review article from an experienced pharmaceutical microbiologist discusses the risks of microbial contamination for the full range of cannabis-derived products and recommends the most appropriate microbiological quality requirements for each product.

What changes need to be adopted in our industry to make the transition to the pharmaceutical industry testing paradigm?

So much is going on in the industry today that researchers are gearing up for more access to the plant, more potential lab discoveries, and better science to truly uncover the secrets of the cannabis plant and find out more about what the plant has to offer.

Part II of this series explores the impact of how material is prepared prior to extraction.

Lesser known cannabinoids and terpenes may be helpful for patients. Here the author shows why, and how patients can choose more effective medical cannabis products.

Here we review the current and pertinent literature in utilizing cannabis derivatives in animals and discuss the future forecast of cannabis in veterinary medicine.

The cannabis industry is constrained by the continued use of acronyms and nonstandard abbreviations for strain naming in lieu of a scientific-based standardized classification convention or lexicon. Applying chemometric tools can result in not only the authentication of a given cannabis cultivar but also provide a quality control mechanism for both cannabis flower and any resulting cannabis-based drugs.

In this installment of “Cannabis Crossroads,” we take a closer look at the hemp revolution, and more specifically, academic hemp research.

Canadian MS Society Invests $1.5 Million in Cannabis Research